Treosulfan
Trecondi (treosulfan) is a small molecule pharmaceutical. Treosulfan was first approved as Trecondi on 2019-06-20. It has been approved in Europe to treat hematopoietic stem cell transplantation.
| Trade Name | Trecondi |
|---|---|
| Common Name | Treosulfan |
| Indication | hematopoietic stem cell transplantation |
| Drug Class | Antineoplastics, alkylating agents (methanesulfonate derivatives) |
